| 000 | 01650 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517071339.0 | ||
| 264 | 0 | _c20170110 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1433-2965 | ||
| 024 | 7 |
_a10.1007/s00198-015-3458-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPopp, A W | |
| 245 | 0 | 0 |
_aRebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. _h[electronic resource] |
| 260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cMay 2016 |
||
| 300 |
_a1917-21 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Diseases, Metabolic _xchemically induced |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDenosumab _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xetiology |
| 650 | 0 | 4 |
_aSpinal Fractures _xetiology |
| 650 | 0 | 4 | _aWithholding Treatment |
| 700 | 1 | _aZysset, P K | |
| 700 | 1 | _aLippuner, K | |
| 773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 27 _gno. 5 _gp. 1917-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-015-3458-6 _zAvailable from publisher's website |
| 999 |
_c25566863 _d25566863 |
||